Cell therapies are the future of healthcare, why are we stru...

The future of healthcare is undeniably heading toward cell therapies, as they offer hope for diseases where, to date, we have not been able to provide treatments or cures.

JP Morgan Week 2025 – Ryan Spencer

Join CEO Ryan Spencer of Dynavax Technologies in a video interview discussing JP Morgan Week 2025

The irony of data in precision medicine: Igniting progress w...

As I regularly engage with pharma executives and biotech founders, a common theme inevitably arises: why is precision medicine taking so long to become a reality, and is technology to blame

Paediatric rare diseases: Children are not small adults

The rise and market race of anti-IL23p19 therapies in IBD: H...

The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two decades.

The UK can’t just be a life sciences lab – we need manufactu...

Rachel Reeves is right: the UK is at the forefront of life sciences, with some world-leading research and innovation.